Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2002

View Archived Issues

Takeda describes new promoters of sAPP secretion and their use in AD and other disorders

Antitumor compounds discovered at Zenyaku Kogyo

Novel antidiabetic compounds in early development at Sumitomo

Mitsubishi Pharma's new chemokine receptor antagonists

Development of long-acting second-generation IL-11 supported by SBIR grant

Two Eisai patents describe novel PAR1 antagonists for restenosis and other uses

Scientists at Servier present new antidiabetic DPP-IV inhibitors

Age-related anticonvulsant effects of MPEP assessed in rats

Results from Oxycyte animal studies

AIDSVAX B/E and AIDSVAX B/B receive fast track designation

Oral formulation of Triapine demonstrates oral bioavailability

OGX-011 enters clinical testing

Two pivotal phase III trials of Alprox-TD completed

Approval granted by FDA for GlaxoSmithKline's Pediarix combination vaccine

Medivir and Paradigm Therapeutics collaborate on protease inhibitor discovery

Extended-release Cipro cleared for uncomplicated urinary tract infections

Third major filing for long-acting insulin analogue

Acute migraine therapy from Pozen filed with the FDA

VRBPAC recommends the FDA approve intranasal influenza vaccine

Cell-permeable MOE RNA oligonucleotide with telomerase-inhibitory effects

Potent and selective factor Xa inhibitor discovered at Mochida

Targeting the uPA system with antibodies as a new approach to cancer therapy

Trifunctional bispecific antibody shows potential for B-cell lymphoma

Chlorthalidone superior to amlodipine or lisinopril in hypertension-related CVD

GW-572016 effective in model of tamoxifen-resistant breast cancer

Antitumor effects of CI-1033 in human breast cancer cells

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026